Business Briefing | Legal News: Glaxo to Pay $45 Million to State Over Drug Marketing

GlaxoSmithKline agreed to pay Louisiana $45 million to settle lawsuits accusing it of improperly marketing the diabetes drug Avandia and other drugs.